Paul A. Stone - 29 Aug 2023 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Reporting relationship: Chief Financial Officer
Issuer ticker: IDYA
Reported as of: 29 Aug 2023
Net transaction value: -$144,352
SEC form: 4
Accepted by SEC: 31 Aug 2023, 17:49:27 UTC
Prior SEC filing: 23 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Jason Throne, as Attorney-in-Fact for Paul A. Stone

Key filing fact

Paul A. Stone filed Form 4 for IDEAYA Biosciences, Inc. (IDYA) on 31 Aug 2023.

Key facts

This page summarizes Paul A. Stone's Form 4 filing for IDEAYA Biosciences, Inc. (IDYA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Aug 2023, 17:49.

Change

Previous filing in this sequence was filed on 23 Aug 2023.
Current net transaction value: -$144,352.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDYA transaction

Common Stock

Sale

Transaction value: $144,352
Shares: -5,000
Change %: -35%
Price: $28.87
Shares after: 9,303
Date: 29 Aug 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 27, 2023.

Footnote F2

This transaction was executed in multiple trades in prices ranging from $28.83 to $29.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.